TOLAK vs TRAZIMERA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. TOLAK and TRAZIMERA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	TOLAK	TRAZIMERA
Rating	72/100	64/100
Pharmacy pays	$0.61 /mL	—
Type	RX	RX
Active ingredient	FLUOROURACIL	TRASTUZUMAB-QYYP
Manufacturer	Hill Dermaceuticals	Pfizer
Dosage forms	Topical	Injectable, Kit
Drug class	Nucleoside Metabolic Inhibitor	—
Boxed warning	None	Boxed warning
Treats	Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms	Breast Neoplasms, Gastrointestinal Neoplasms

tolak trazimera

Rating

72/100

64/100

Pharmacy pays

$0.61 /mL

—

Type

Active ingredient

FLUOROURACIL

TRASTUZUMAB-QYYP

Manufacturer

Hill Dermaceuticals

Pfizer

Dosage forms

Topical

Injectable, Kit

Drug class

Nucleoside Metabolic Inhibitor

—

Boxed warning

None

Boxed warning

Treats

Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms

Breast Neoplasms, Gastrointestinal Neoplasms

Frequently asked questions

Which is better-rated, Tolak or Trazimera?

By our independent rating, Tolak scores higher — 3.6 vs 3.2 out of 5 for Trazimera. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Tolak and Trazimera?

Tolak contains Fluorouracil, while Trazimera contains Trastuzumab-Qyyp — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.